Journal of Population Research ( IF 1.6 ) Pub Date : 2022-08-31 , DOI: 10.1007/s12546-022-09289-1 Simona Bignami-Van Assche 1 , Daniela Ghio 2
Background
The case fatality rate (CFR) is one of the most important measures for monitoring disease progression and evaluating appropriate policy health measures over the course of the COVID-19 pandemic. To remove biases arising from the age structure of COVID-19 cases in international comparisons of the CFR, existing studies have relied mainly on direct standardisation.
Objective
We propose and validate a synthetic indicator of COVID-19 fatality (SCFR) that improves its comparability across countries by adjusting for the age and sex structure of COVID-19 cases without relying on the arbitrary choice of a standard population.
Results
Contrary to what comparisons of the crude CFR suggest, differences in COVID-19 fatality across countries according to the proposed SCFR are not very stark. Importantly, once we adjust for the age structure of COVID-19 cases, the higher case fatality among men emerges as the main driver of international differences in COVID-19 CFR.
Conclusions
The SCFR is a simple indicator that is useful for monitoring the fatality of SARS-CoV-2 mutations and the efficacy of health policy measures for COVID-19, including vaccination.
Contributions
(1) A simple synthetic indicator of COVID-19 fatality that improves its comparability across countries by adjusting for the age and sex structure of COVID-19 cases; (2) Evidence that sex differences in COVID-19 fatality drive international differences in the overall CFR.
中文翻译:
比较各国 COVID-19 死亡人数:综合人口指标
背景
病死率 (CFR) 是在 COVID-19 大流行期间监测疾病进展和评估适当政策卫生措施的最重要指标之一。为了消除 CFR 国际比较中因 COVID-19 病例年龄结构而产生的偏差,现有研究主要依赖于直接标准化。
客观的
我们提出并验证了一种 COVID-19 死亡率综合指标 (SCFR),该指标通过调整 COVID-19 病例的年龄和性别结构,而不依赖于标准人群的任意选择,提高了其在各国之间的可比性。
结果
与粗略 CFR 的比较表明的相反,根据拟议的 SCFR,各国之间的 COVID-19 死亡率差异并不十分明显。重要的是,一旦我们调整了 COVID-19 病例的年龄结构,男性较高的病死率就成为了 COVID-19 CFR 国际差异的主要驱动因素。
结论
SCFR 是一个简单的指标,可用于监测 SARS-CoV-2 突变的致死率以及针对 COVID-19 的卫生政策措施(包括疫苗接种)的有效性。
贡献
(1) 一个简单的 COVID-19 死亡综合指标,通过调整 COVID-19 病例的年龄和性别结构,提高其在各国之间的可比性; (2) 有证据表明,COVID-19 死亡人数的性别差异导致总体病死率存在国际差异。